Search results for "hepatitis"
Spotlight on early transplants for alcoholic liver disease
Two studies showed that providing liver transplants to patients who hadn't abstained from alcohol for six months didn't reduce survival rates, while another found that relatively few patients with severe alcoholic hepatitis experience spontaneous remission.
https://gastroenterology.acponline.org/archives/2021/08/27/5.htm
27 Aug 2021
Tenofovir alafenamide may safely replace tenofovir disoproxil fumarate in patients with drug-resistant HBV, trial finds
An industry-funded randomized trial found that tenofovir alafenamide could be substituted for tenofovir disoproxil fumarate in patients with multidrug-resistant hepatitis B virus (HBV) for improved bone and renal safety without a loss of efficacy; however, the former drug was associated with greater increases in body weight and cholesterol levels.
https://gastroenterology.acponline.org/archives/2021/05/28/4.htm
28 May 2021
Transplant of HCV-infected kidneys to HCV-negative recipients yields good outcomes at 12 months
The study authors concluded that their results should encourage efforts to increase use of hepatitis C virus (HCV)-infected kidneys and called for larger confirmatory trials.
https://gastroenterology.acponline.org/archives/2018/08/24/7.htm
24 Aug 2018
Spotlight on alcohol-related liver disease
Recent research identified risk factors that predict the severity of alcohol-related liver disease, distinct patterns of alcohol use that may affect survival after liver transplantation for alcoholic hepatitis, potential effects on the microbiome, and more.
https://gastroenterology.acponline.org/archives/2020/12/18/5.htm
18 Dec 2020
HCV treatment appeared successful for patients who hadn't responded to previous direct-acting antivirals, industry-funded study finds
The study included two phase 3 trials: POLARIS-1, in which patients with chronic hepatitis C virus (HCV) had previously taken a regimen containing an NS5A inhibitor, and POLARIS-4, in which patients had previously received a direct-acting antiviral agent regimen that did not include an NS5A inhibitor.
https://gastroenterology.acponline.org/archives/2017/06/23/3.htm
23 Jun 2017
Best practices for HCV care include less invasive testing for many patients, says ACP
The College's new advice on treating hepatitis C virus (HCV) identifies patients who can be safely treated in primary care with laboratory monitoring limited to the beginning and end of treatment and no invasive testing.
https://gastroenterology.acponline.org/archives/2020/10/23/6.htm
23 Oct 2020
MKSAP quiz: HCV-related cirrhosis with decompensation
This month's quiz asks readers to determine the next step in management for a 64-year-old man with hepatitis C virus (HCV)-related decompensation.
https://gastroenterology.acponline.org/archives/2019/03/22/4.htm
22 Mar 2019
MKSAP Quiz: Chronic pain and a history of cirrhosis
This month's quiz asks readers to determine the most appropriate treatment for a 66-year-old patient with chronic back pain and a history of cirrhosis, osteoporosis, and stage 2 chronic kidney disease.
https://gastroenterology.acponline.org/archives/2022/02/25/4.htm
25 Feb 2022
CDC updates guidance on responding to health care exposures to HCV
The CDC called for hepatitis C virus (HCV) testing of both the patient and exposed personnel as soon as possible after an exposure incident, preferably within 48 hours.
https://gastroenterology.acponline.org/archives/2020/08/28/2.htm
28 Aug 2020
Treatment algorithm updated for chronic HBV
The recommendations address use of newer therapies and are intended to offer guidance on treating chronic hepatitis B virus (HBV) infection while additional antiviral agents are in development.
https://gastroenterology.acponline.org/archives/2021/08/27/1.htm
27 Aug 2021